Study of the causes of certain blood cancers
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study looks at what leads to specific blood cancers and related blood disorders. If you have one of the listed conditions (or are being evaluated for it), you may be asked to join research that helps doctors understand why these illnesses happen.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have a suspected or confirmed diagnosis of AL, LPD, MDS, or MPD
- This is for people of any age
- You must be willing and able to sign informed consent
- If you are under 18, a parent or guardian must agree (guardian consent)
- Your condition should fit one of the listed blood diagnoses
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks healthy adults to provide blood, bone marrow (if needed), skin, saliva, and stool samples. Scientists use these samples to compare patterns related to myeloid (bone-marrow) blood cancers, which may help future research and tests.
This study looks at families where more than one person has a blood cell disorder (lymphoproliferative disorder) to understand why it runs in families. If you or a relative have this condition, you may help researchers learn more about it.
This study is looking at how a certain biological pathway (called BMP) affects the progression of blood cancers like MDS and AML. By understanding this, doctors hope to find better ways to predict or treat these conditions.
This study looks at gene patterns in people with blood cancers to better understand the disease and find possible treatments. If you are being tested for a blood cancer or have a blood cancer that came back or got worse, you may be able to join.
This study looks at genetic (DNA) factors that may contribute to certain blood disorders. You may be invited if you or a close family member is receiving care for a blood condition like MDS or MPN, and the study also includes related relatives.
This study collects and stores blood and bone marrow samples from young people with certain blood cancers so doctors can do genetic (“genomic”) testing now and in the future. It may help improve understanding of the disease and support better matching of care for patients.
Hear when a new Acute Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.